The T120P or M172V mutation on rv2172c confers high level para-aminosalicylic acid resistance in Mycobacterium tuberculosis
Although para-aminosalicylic acid (PAS) has been used to treat tuberculosis for decades, mechanisms of resistance to this drug in Mycobacterium tuberculosis (M. tuberculosis) clinical isolates have not been thoroughly investigated. Previously, we found that decreased methylenetetrahydrofolate reduct...
שמור ב:
| Principais autores: | , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Taylor & Francis Group
2024-12-01
|
| סדרה: | Emerging Microbes and Infections |
| נושאים: | |
| גישה מקוונת: | https://www.tandfonline.com/doi/10.1080/22221751.2024.2374030 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
